Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Dr Lalchandani Labs is a provider of diagnostic and related healthcare tests and services.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
Dr Lalchandani Labs Ltd - 541299 - Revised Financial Statement For The Half Year And Year Ended March 31, 2024 Pursuant To The Communication Made By Exchange Dated October 03, 2024 | Download
Dr Lalchandani Labs Ltd - 541299 - Revised Financial Statement For The Half Year And Year Ended March 31, 2024 Pursuant To The Communication Made By Exchange Dated October 03, 2024 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant